Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective
Year of publication: |
2007
|
---|---|
Authors: | Heeg, Bart ; Damen, Joep ; Van Hout, Ben |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 25.2007, 12, p. 1063-1082
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Antiplatelets | Aspirin | Cardiovascular-disorders | Clopidogrel | Cost-effectiveness | Cost-utility | Dipyridamole |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Kourlaba, Georgia, (2012)
-
Lamotte, Mark, (2006)
-
Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention
Heeg, Bart M.S., (2007)
- More ...
-
Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events
Heeg, Bart, (2007)
-
A Pharmacoeconomic Analysis of Compliance Gains on Antipsychotic Medications
Damen, Joep, (2008)
-
Cost Effectiveness of Long-Acting Risperidone in Sweden
Hensen, Marja, (2010)
- More ...